Showing 1,021 - 1,040 results of 1,775 for search '"Therapy"', query time: 0.06s Refine Results
  1. 1021

    Psychological and autonomous nervous system features of functional gastric dyspepsia and irritable bowel syndrome, duloxetine treatment efficacy by A. P. Pogromov, G. M. Dyukova, M. L. Leonova

    Published 2012-06-01
    “…According to aims of investigation all FGID patient received duloxetine treatment. After cessation of therapy all patients were monitored for one year with no relation to duration of treatment. …”
    Get full text
    Article
  2. 1022

    Modern approaches to treatment of acute anaerobic paraproctitis by M. A. Yegorkin

    Published 2011-05-01
    “…In postoperative period antibiotic therapy by carbapenems or last generation penicillins in maximally allowed doses, treatment of organ dysfunction, control of regenerative processes in the vast wounds formed after radical operations is recommended.…”
    Get full text
    Article
  3. 1023

    The Main Statements of the Consensus “Maastricht-VI” (2022) on the Diagnostics and Treatment of <i>Helicobacter pylori</i> Infection by A. A. Sheptulin

    Published 2023-02-01
    “…The publication of materials of the new consensus “Maastricht-VI” will contribute to improving the results of H. рylori eradication therapy.…”
    Get full text
    Article
  4. 1024

    Polypragmasy at treatment of <i>H. pylori</i> infection in patients with concomitant diseases of other organs and systems. How to prevent side effects related to drug interactions? by S. G. Burkov, N. V. Shornikova

    Published 2011-05-01
    “…Being based on literature data and own experience, authors demonstrated, that drug interactions are observed in vast majority of cases at simultaneous prescription of five drugs and more. As eradication therapy implicates addition to treatment of at least 3 pharmaceuticals of which antibiotics are strictly specified, it is extremely desirable to choose proton pump inhibitor (PPI) with lower affinity to cytochrome Р450. …”
    Get full text
    Article
  5. 1025

    Intravenous Ketamine for Suicidal Behavior in Severe Depression with Psychotic Features by T. V. Pavan Kumar, Divya Bolla, Raj Kiran Donthu, Anzory Pathak

    Published 2025-01-01
    “…Depression is the leading cause of suicide, and antidepressants and modified electroconvulsive therapy (mECT) are the preferred treatment modalities. …”
    Get full text
    Article
  6. 1026
  7. 1027

    Florida Vegetable Gardening Guide by Sydney Park Brown, Danielle Treadwell, James M. Stephens, Susan Webb

    Published 2015-12-01
    “… Vegetable gardening offers fresh air, sunshine, exercise, enjoyment, mental therapy, nutritious fresh vegetables, and economic savings, as well as many other benefits. …”
    Get full text
    Article
  8. 1028

    Discussion of <i>Helicobacter pylori</i> infection issue in reports of the 19-th United European Gastroenterology Week by A. A. Sheptulin, Yu. V. Evsyutina

    Published 2012-09-01
    “…Overcoming of this resistance is promoted by new modes of eradication: sequential, «concomitant» triple therapy with levofloxacin. The choice of the specific mode depends on level of clarithromycin resistance in this region.Conclusion. …”
    Get full text
    Article
  9. 1029

    Multi-omics uncovers immune-modulatory molecules in plasma contributing to resistance exercise-ameliorated locomotor disability after incomplete spinal cord injury by Ren Zhou, Jibao Chen, Yunhan Tang, Chuijin Wei, Ping Yu, Xinmei Ding, Li’ao Zhu, Jiajia Yao, Zengqiang Ouyang, Jing Qiao, Shumin Xiong, Liaoliao Dong, Tong Yin, Haiqing Li, Ye Feng, Lin Cheng

    Published 2025-02-01
    “…Abstract Background Exercise rehabilitation therapy has garnered widespread recognition for its beneficial effects on the restoration of locomotor function in individuals with spinal cord injury (SCI). …”
    Get full text
    Article
  10. 1030

    Telomerase inhibiting phytochemicals derived from Blumea eriantha for cancer treatment: A comprehensive computational analysis by Rahil Ummar Faruk Abbu, Shaik Mohammad Abdul Fayaz, Divyashree M S, Raghu Chandrashekhar H, Prasanna Kumar Reddy Gayam, Archana Mahadev Rao

    Published 2025-02-01
    “…Therefore, following experimental validation, Tyrphostin AG494 is the most suitable and prospective candidate for telomerase inhibition and cancer therapy.…”
    Get full text
    Article
  11. 1031

    Primary Terminal Haemochromatosis in a 50 Year-Old Patient by M. I. Gonik, M. S. Zharkova, O. Yu. Kiseleva, E. V. Berezina, Sh. A. Ondos, Yu. V. Lerner, E. A. Kogan, V. T. Ivashkin

    Published 2021-04-01
    “…Despite a cardiovascular and renal failure compensation therapy and albumin transfusion, the patient died. …”
    Get full text
    Article
  12. 1032

    Advances in personalized gastroenterology and hepatology 2016 by E. Blum Hubert

    Published 2016-08-01
    “…Molecular and cell biology have resulted in major advances in our understanding of disease pathogenesis as well as in novel strategies for the diagnosis, therapy and prevention of human diseases. Based on modern molecular, genetic, epigenetic microbiologic and biochemical analyses it is, on the one hand, possible to identify disease-related point mutations and single nucleotide polymorphisms in the context of genomewide association analyses (GWAS). …”
    Get full text
    Article
  13. 1033

    The treatment of irritable bowel syndrome from the modern views on the disease pathogenesis by Ye. A. Poluektova, S. Yu. Kuchumova, A. A. Sheptulin, V. T. Ivashkin

    Published 2013-03-01
    “…The topical corticosteroid drugs, mesalazine and probiotics can take their own place in the therapy scheme in the future.Conclusion. The establishing of the IBS new pathogenic mechanisms gives more possibilities for the treatment.…”
    Get full text
    Article
  14. 1034

    Experience in the Treatment of Irritable Bowel Syndrome Developed after a New Coronavirus Infection (COVID-19) by R. G. Myazin

    Published 2022-05-01
    “…Clinical and laboratory data of 32 patients with IBS who had a history of COVID-19 pneumonia were analyzed. Course therapy with Kolofort® is prescribed according to the standard scheme for 3 months. …”
    Get full text
    Article
  15. 1035

    “Subarachnoid block in active burn injury”: A case report of anesthetic challenges and considerations by Rutuja Gohad, Sudha S. Jain, Shubham Rahane, Dushyant Bawiskar

    Published 2025-01-01
    “…It should be considered in burn patients where it is impossible for the patient to flex, where the intervertebral space is very low, or when there is a burn present over the spinal region. Ultimately, early therapy and mobility goals, two essential components of burn care and rehabilitation, can be achieved with the use of paramedian regional anesthesia.…”
    Get full text
    Article
  16. 1036

    Critical Issues in an Unmotivated Patient with Alcohol Dependence by Nidhi Vadhavekar, Saloni Chatwani, Avinash Desousa, Hardik Sheth, Kavitha V. Dongerkery, Pradnya Deolekar

    Published 2025-01-01
    “…The patient’s AUD was characterized by cluster B personality disorder traits, and treatment involved a multidisciplinary approach (acamprosate, sertraline, nicotine replacement therapy, psychotherapy, and admission into a rehabilitation center). …”
    Get full text
    Article
  17. 1037

    Mucormycosis in COVID-19 Patients – A Case Series from a Dental College in South India by Annapoorani Sevagaperumal, A. Christy Winnifred, T. Jones R. Deva Thambi

    Published 2023-07-01
    “…COVID-19 infection results in an immunocompromised state due to the steroid therapy administered to patients and the infection itself. …”
    Get full text
    Article
  18. 1038

    Epigenetics of cancer drug resistance by Sayandeep Mukherjee, Ronit Dey, Subhabrata Guha, Nabendu Murmu, Gaurav Das

    Published 2023-07-01
    “…The capability to change or reprogram the landscape of epigenetics in the epigenome of cancer is the most promising and guaranteed targeted therapy that leads to the reversibility of drug resistance and new modalities of treatment in cancer. …”
    Get full text
    Article
  19. 1039

    Study on the efficacy of furosemide nebulization in transient tachypnea of newborn – A case–control study by A. Kaivalya, R. H. Gobbur, S. S. Kalyan Shettar, M. M. Patil

    Published 2024-07-01
    “…CONCLUSION: Furosemide nebulization is a safe and effective treatment for TTN, offering superior outcomes in terms of oxygen therapy reduction, faster recovery, and shorter NICU stays compared to normal saline nebulization.…”
    Get full text
    Article
  20. 1040

    Pharmaceutical hemostasis at peptic ulcer bleeding: state-of-the-art and perspectives by A. A. Schegolev, O. A. Al Sabunchi, S. A. Valetov, A. V. Pavlychev, Ye. A. Klochneva

    Published 2013-07-01
    “…In the first group no relapses of bleeding or mortality was detected, in the second group in 4 (10%) patients there was relapse of bleeding, that allows to assume higher efficacy of therapeutic hemostasis by the parenteral form of proton pump inhibitors within complex therapy.Conclusions. Application of Omez, lyophilizate for infusions, allows to improve treatment results in patients of the main group, reduces risk of hemorrhage relapse and, therefore mortality and urgent surgery rates.…”
    Get full text
    Article